About
Magnosco GmbH is a Berlin-based medical technology company that specializes in advanced skin cancer diagnostics. Founded in 2014, it focuses on developing innovative diagnostic devices that utilize laser technology and artificial intelligence to enhance the accuracy and efficiency of melanoma detection. The company's flagship product, the DermaFC, assists dermatologists by objectively assessing skin lesions with laser light and AI algorithms. This technology aims to reduce unnecessary biopsies and shorten waiting times for lab results. Magnosco also offers the Magnos® digital dermatoscope, which, along with its app, allows for efficient management and communication of dermoscopic images, providing high-resolution magnification of skin lesions for detailed examination. Magnosco's solutions are designed for dermatologists and medical professionals, supporting clinical decision-making with objective, AI-enhanced diagnostic data. The company's mission is reflected in its name, which means "I recognize the melanoma," highlighting its commitment to early and accurate melanoma detection.
Technologies
Keywords
Company Information
-
Employees 13
-
Founded 2014
Location
2 Justus-von-Liebig-Strasse, Berlin, Berlin, Germany, 12489
